Patient Transitioning From Exubera® Inhalation Powder to Technosphere® Insulin Inhalation Powder
Public ClinicalTrials.gov record NCT01798914. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Patient Transfer Program for Transitioning From Exubera® (Insulin Human [rDNA Origin]) Inhalation Powder to Technosphere® Insulin (Insulin Human [rDNA Origin]) Inhalation Powder
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to allow patients with specific needs for inhaled insulin to continue with inhaled insulin therapy using Technosphere Insulin after Exubera was withdrawn from the market.
Study identification
- NCT ID
- NCT01798914
- Recruitment status
- No Longer Available
- Study type
- Expanded access
- Phase
- Not listed
- Enrollment
- Not listed
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- Not listed
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 30, 2008
- Primary completion
- Mar 31, 2015
- Completion
- Apr 30, 2015
- Last update posted
- Jan 19, 2016
2008 – 2015
United States locations
- U.S. sites
- 14
- U.S. states
- 10
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Endocrinology Associates | Montgomery | Alabama | 36106 | — |
| Diabetes and Endocrine Consultants P.C. | Montgomery | Alabama | 36117 | — |
| University of Miami Diabetes Research Institute | Miami | Florida | 33136 | — |
| Dr. Rife and Associates Family Medicine | Orland Park | Illinois | 60467 | — |
| Highland Clini-Endocrinology | Shreveport | Louisiana | 71105 | — |
| Annapolis Internal Medicine LLC | Annapolis | Maryland | 21401 | — |
| Nallin Family Healthcare | Cumberland | Maryland | 21502 | — |
| Center for Diabetes and Endocrinology | Portsmouth | New Hampshire | 03801 | — |
| North Country Community Physicians | Glen Cove | New York | 11542 | — |
| Great Neck Medical Group | Great Neck | New York | 11021 | — |
| North Shore Diabetes and Endocrine Associates | New Hyde Park | New York | 11042 | — |
| Mountain Diabetes and Endocrine Center | Asheville | North Carolina | 28803 | — |
| Primary Care Wakefield | Wakefield | Rhode Island | 02879 | — |
| Endocrinology Associates Inc. | Roanoke | Virginia | 24016 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01798914, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 19, 2016 · Synced Sep 1, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01798914 live on ClinicalTrials.gov.